These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 16005039)

  • 21. T cell line passage can select for pre-existing neutralization-sensitive variants from the quasispecies of primary human immunodeficiency virus type-1 isolates.
    Quakkelaar ED; Beaumont T; van Nuenen AC; van Alphen FP; Boeser-Nunnink BD; van 't Wout AB; Schuitemaker H
    Virology; 2007 Mar; 359(1):92-104. PubMed ID: 17052738
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The impact of envelope glycoprotein cleavage on the antigenicity, infectivity, and neutralization sensitivity of Env-pseudotyped human immunodeficiency virus type 1 particles.
    Herrera C; Klasse PJ; Michael E; Kake S; Barnes K; Kibler CW; Campbell-Gardener L; Si Z; Sodroski J; Moore JP; Beddows S
    Virology; 2005 Jul; 338(1):154-72. PubMed ID: 15932765
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antigp41 antibodies fail to block early events of virological synapses but inhibit HIV spread between T cells.
    Massanella M; Puigdomènech I; Cabrera C; Fernandez-Figueras MT; Aucher A; Gaibelet G; Hudrisier D; García E; Bofill M; Clotet B; Blanco J
    AIDS; 2009 Jan; 23(2):183-8. PubMed ID: 19098487
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Elimination of HIV-1 infection by treatment with a doxorubicin-conjugated anti-envelope antibody.
    Johansson S; Goldenberg DM; Griffiths GL; Wahren B; Hinkula J
    AIDS; 2006 Oct; 20(15):1911-5. PubMed ID: 16988511
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antibody-dependent cell-mediated cytotoxicity can protect PBMC from infection by cell-associated HIV-1.
    Hildreth JE; Hampton R; Halsey NA
    Clin Immunol; 1999 Feb; 90(2):203-12. PubMed ID: 10080832
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Viral evolution in macaques coinfected with CCR5- and CXCR4-tropic SHIVs in the presence or absence of vaccine-elicited anti-CCR5 SHIV neutralizing antibodies.
    Burke B; Derby NR; Kraft Z; Saunders CJ; Dai C; Llewellyn N; Zharkikh I; Vojtech L; Zhu T; Srivastava IK; Barnett SW; Stamatatos L
    Virology; 2006 Nov; 355(2):138-51. PubMed ID: 16920175
    [TBL] [Abstract][Full Text] [Related]  

  • 27. HIV sensitivity to neutralization is determined by target and virus producer cell properties.
    Mann AM; Rusert P; Berlinger L; Kuster H; Günthard HF; Trkola A
    AIDS; 2009 Aug; 23(13):1659-67. PubMed ID: 19581791
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Resistance of HIV-1 to the broadly HIV-1-neutralizing, anti-carbohydrate antibody 2G12.
    Huskens D; Van Laethem K; Vermeire K; Balzarini J; Schols D
    Virology; 2007 Apr; 360(2):294-304. PubMed ID: 17123566
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Differential glycosylation, virion incorporation, and sensitivity to neutralizing antibodies of human immunodeficiency virus type 1 envelope produced from infected primary T-lymphocyte and macrophage cultures.
    Willey RL; Shibata R; Freed EO; Cho MW; Martin MA
    J Virol; 1996 Sep; 70(9):6431-6. PubMed ID: 8709276
    [TBL] [Abstract][Full Text] [Related]  

  • 30. HIV-1 Envgp140 trimers elicit neutralizing antibodies without efficient induction of conformational antibodies.
    Bower JF; Li Y; Wyatt R; Ross TM
    Vaccine; 2006 Jun; 24(26):5442-51. PubMed ID: 16621193
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of mutations on HIV-1 infectivity and neutralization involving the conserved NNNT amino acid sequence in the gp120 V3 loop.
    Polzer S; Müller H; Schreiber M
    FEBS Lett; 2009 Apr; 583(7):1201-6. PubMed ID: 19285979
    [TBL] [Abstract][Full Text] [Related]  

  • 32. High level serum neutralizing antibody against HIV-1 in Chinese long-term non-progressors.
    Wang Q; Shang H; Han X; Zhang Z; Jiang Y; Wang Y; Dai D; Diao Y
    Microbiol Immunol; 2008 Apr; 52(4):209-15. PubMed ID: 18426395
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Membrane embedded HIV-1 envelope on the surface of a virus-like particle elicits broader immune responses than soluble envelopes.
    McBurney SP; Young KR; Ross TM
    Virology; 2007 Feb; 358(2):334-46. PubMed ID: 17011011
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Chimeric HIV-1 containing SIV matrix exhibit enhanced assembly in murine cells and replicate in a cell-type-dependent manner in human T cells.
    Chen P; Hübner W; Riviere K; Liu YX; Chen BK
    Virology; 2006 May; 349(1):1-12. PubMed ID: 16563454
    [TBL] [Abstract][Full Text] [Related]  

  • 35. CD4-independent use of the CCR5 receptor by sequential primary SIVsm isolates.
    Laurén A; Vincic E; Hoshino H; Thorstensson R; Fenyö EM
    Retrovirology; 2007 Jul; 4():50. PubMed ID: 17645788
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Increased envelope spike density and stability are not required for the neutralization resistance of primary human immunodeficiency viruses.
    Karlsson GB; Gao F; Robinson J; Hahn B; Sodroski J
    J Virol; 1996 Sep; 70(9):6136-42. PubMed ID: 8709238
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The envelope gene is a cytopathic determinant of CCR5 tropic HIV-1.
    Olivieri K; Scoggins RM; Bor YC; Matthews A; Mark D; Taylor JR; Chernauskas D; Hammarskjöld ML; Rekosh D; Camerini D
    Virology; 2007 Feb; 358(1):23-38. PubMed ID: 16999983
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Development of a safe and rapid neutralization assay using murine leukemia virus pseudotyped with HIV type 1 envelope glycoprotein lacking the cytoplasmic domain.
    Kim YB; Lee MK; Han DP; Cho MW
    AIDS Res Hum Retroviruses; 2001 Dec; 17(18):1715-24. PubMed ID: 11788023
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mitigation of variation observed in a peripheral blood mononuclear cell (PBMC) based HIV-1 neutralization assay by donor cell pooling.
    Wieczorek L; Brown BK; Delsarto Macedo C; Wesberry-Schmierer M; Ngauy V; Rosa Borges A; Michael NL; Marovich MA; Montefiori DC; Polonis VR
    Virology; 2013 Dec; 447(1-2):240-8. PubMed ID: 24210120
    [TBL] [Abstract][Full Text] [Related]  

  • 40. HIV envelope induces a cascade of cell signals in non-proliferating target cells that favor virus replication.
    Cicala C; Arthos J; Selig SM; Dennis G; Hosack DA; Van Ryk D; Spangler ML; Steenbeke TD; Khazanie P; Gupta N; Yang J; Daucher M; Lempicki RA; Fauci AS
    Proc Natl Acad Sci U S A; 2002 Jul; 99(14):9380-5. PubMed ID: 12089333
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.